Sequences
Sign in

Sample result

Human insulin's gene

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Sign inAll samples

The search

Query
INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
From
NCBI RefSeq NM_000207.3, bases 60 to 392
Search
DNA → Patent DNA · Automatic (BLAST)
Set
Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
3,194 sequences, 1,584 publications, 1,066 families

Each query returns up to 5,000 sequences and 5 alignments per sequence. BLAST may miss matches. These results do not establish patentability.

Patents

1,584 publications in 1,066 families match these filters.

  1. WO 2008118390-A12008-10-02

    Biomarkers for diagnostic and therapeutic methods

    Wayne State University (US)

    Query Match 27.9%Identity 100.0%

    Best alignment

    Query 169 to 261, hit 1 to 93. Positions start at 1 and include both ends.

    Query 169 GAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGC 228
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 GAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGC 60

Query 229 CTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAG 261
          |||||||||||||||||||||||||||||||||
Hit    61 CTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAG 93

    93 of 93 identical, no gaps.

  2. WO 2009101672-A2009-08-20

    Fusion protein containing highly-expressed and -secreted insulin precursor, DNA encoding same, and method of producing insulin

    ITOHAM FOODS Inc,SHIGEZO UDAKA

    Query Match 27.5%Identity 100.0%

    Best alignment

    Query 72 to 165, hit 93 to 186. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit    93 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 152

Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGC 165
          |||| |||||||||||||||||||||||||||||
Hit   153 GGAAAGAGGCTTCTTCTACACACCCAAGACCCGC 186

    93 of 94 identical, no gaps.

  3. JP 2022531592-A2022-07-07

    PAR2 Modulation and Methods Thereof

    Janssen Biotech Inc,Changlu Liu,Belinda Liu,Grace Steemers-Lee,Siquan Sun

    Query Match 27.5%Identity 100.0%

    Best alignment

    Query 1 to 94, hit 1 to 94. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60

Query 61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCG 94
         |||||||||||||||||||||||||||||| |||
Hit   61 CCAGCCGCAGCCTTTGTGAACCAACACCTGGGCG 94

    93 of 94 identical, no gaps.

  4. WO 0131037-A22001-05-03

    Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases

    YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL)

    Query Match 27.3%Identity 100.0%Family of 2

    Best alignment and family

    Query 13 to 264, hit 10 to 198. Positions start at 1 and include both ends.

    Query  13 ATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCC 72
          |||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
Hit    10 ATGCGCCTCCTGCCGCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCA--- 66

Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
                                  |||||||||||||||||||||||||| ||| |||||
Hit    67 ------------------------TCACACCTGGTGGAAGCTCTCTACCTGGTGAGCGGG 102

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
          ||||| ||||||||||||||||| |||||||||   ||||||||||
Hit   103 GAACGTGGCTTCTTCTACACACCGAAGACCCGCATTGAGGCAGAGG-------------- 148

Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
                                | ||||||||||||||||| || |||||||||||||||
Hit   149 ----------------------CGGGTGCAGGCAGCCTGCAACCGTTGGCCCTGGAGGGG 186

Query 253 TCCCTGCAGAAG 264
          |||||||| |||
Hit   187 TCCCTGCAAAAG 198

    177 of 252 identical, 63 gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  5. US 8501189-B22013-08-06

    Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases

    Query Match 27.3%Identity 100.0%

    Best alignment

    Query 13 to 264, hit 10 to 198. Positions start at 1 and include both ends.

    Query  13 ATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCC 72
          |||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
Hit    10 ATGCGCCTCCTGCCGCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCA--- 66

Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
                                  |||||||||||||||||||||||||| ||| |||||
Hit    67 ------------------------TCACACCTGGTGGAAGCTCTCTACCTGGTGAGCGGG 102

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
          ||||| ||||||||||||||||| |||||||||   ||||||||||
Hit   103 GAACGTGGCTTCTTCTACACACCGAAGACCCGCATTGAGGCAGAGG-------------- 148

Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
                                | ||||||||||||||||| || |||||||||||||||
Hit   149 ----------------------CGGGTGCAGGCAGCCTGCAACCGTTGGCCCTGGAGGGG 186

Query 253 TCCCTGCAGAAG 264
          |||||||| |||
Hit   187 TCCCTGCAAAAG 198

    177 of 252 identical, 63 gaps.

  6. EP 1211314-A22002-06-05

    Expression of a human insulin precursor in p. Pastoris

    LABORATORIOS BETA S.A. (AR)

    Query Match 27.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  7. JP 2005514060-A2005-05-19

    Albumin Fusion Proteins

    Human Genome Sciences Inc,Delta Biotechnology Limited, Principia Pharmaceutical Corporation

    Query Match 27.0%Identity 100.0%Family of 20

    Best alignment and family

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

    Family of 20

    Grouped by a shared priority claim, US 60/341811.

  8. US 7141547-A2006-11-28

    Albumin fusion proteins comprising GLP-1 polypeptides

    Human Genome Sciences, Inc.

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  9. US 7592010-A2009-09-22

    Albumin fusion proteins

    Human Genome Sciences, Inc. and Delta Biotechnology Limited

    Query Match 27.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. US 8012464-B22011-09-06

    G-CSF-albumin fusion proteins

    Human Genome Sciences, Inc.

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  11. US 8211439-B22012-07-03

    Albumin fusion proteins comprising insulin polypeptides

    Human Genome Sciences, Inc.

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  12. JP 2015501819-A2015-01-19

    HUMAN INSULIN ANALOGUE AND ACYLATED DERIVATIVE THEREOF

    Shanghai hengrui pharmaceutical co LTD,Jiangsu hengrui medicine CO LTD

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  13. EP 2990417-A12016-03-02

    ALBUMIN INSULIN FUSION PROTEIN

    HUMAN GENOME SCIENCES INC

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  14. US 9458219-B22016-10-04

    Human insulin analogue and acylated derivative thereof

    Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd.

    Query Match 27.0%Identity 100.0%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACC 90

    90 of 90 identical, no gaps.

  15. JP 2007037434-A2007-02-15

    Reporter gene for quantitative measurement of pancreatic beta cells.

    Yamaguchi University

    Query Match 26.7%Identity 100.0%

    Best alignment

    Query 171 to 259, hit 648 to 736. Positions start at 1 and include both ends.

    Query 171 GGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCT 230
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit   648 GGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCT 707

Query 231 GCAGCCCTTGGCCCTGGAGGGGTCCCTGC 259
          |||||||||||||||||||||||||||||
Hit   708 GCAGCCCTTGGCCCTGGAGGGGTCCCTGC 736

    89 of 89 identical, no gaps.

  16. KR 1020150034094-A2015-04-02

    Transgenic plant expressed from recombinant prominiinsulin and method thereof

    INDUSTRY-ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIVERSITY

    Query Match 26.3%Identity 100.0%

    Best alignment

    Query 70 to 159, hit 81 to 170. Positions start at 1 and include both ends.

    Query  70 GCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGC 129
          || |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit    81 GCTTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGC 140

Query 130 GGGGAACGAGGCTTCTTCTACACACCCAAG 159
          ||||||||||||||||||||||||||||||
Hit   141 GGGGAACGAGGCTTCTTCTACACACCCAAG 170

    89 of 90 identical, no gaps.

  17. KR 1020220092036-A2022-07-01

    Circular Nucleic Acid Template for DNA Hydrogel Production and Protein Synthesis System using The Same

    Progeneer Inc

    Query Match 26.3%Identity 98.9%

    Best alignment

    Query 73 to 162, hit 138 to 49. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit   138 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 79

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          |||||||||||||||||||||||||| |||
Hit    78 GAACGAGGCTTCTTCTACACACCCAACACC 49

    89 of 90 identical, no gaps.

  18. JP 2023500643-A2023-01-10

    PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL

    PROGENEER INC

    Query Match 26.3%Identity 98.9%Family of 4

    Best alignment and family

    Query 73 to 162, hit 154 to 65. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit   154 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 95

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          |||||||||||||||||||||||||| |||
Hit    94 GAACGAGGCTTCTTCTACACACCCAACACC 65

    89 of 90 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, KR 10-2019-0136416.

  19. EP 0393502-A11990-10-24

    Soluble interferon-gamma receptors and methods for their production.

    F. HOFFMANN-LA ROCHE AG

    Query Match 26.1%Identity 87.7%

    Best alignment

    Query 197 to 333, hit 1118 to 1254. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCC 256
           |||||||||| || ||||| || |||||   ||| ||| ||||||| ||||||| | |||
Hit   1118 TGGAGCTGGGTGGAGGCCCGGGGGCAGGTGACCTTCAGACCTTGGCACTGGAGGTGGCCC 1177

Query  257 TGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGG 316
            ||||||||| ||||| ||||| || ||||| |||||||||||||| |||||||| ||||
Hit   1178 GGCAGAAGCGCGGCATCGTGGATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGG 1237

Query  317 AGAACTACTGCAACTAG 333
           |||||||||||||||||
Hit   1238 AGAACTACTGCAACTAG 1254

    117 of 137 identical, no gaps.

  20. KR 1020027004399-A2002-04-04

    Vascular Endothelial Growth Factor-2

    Query Match 26.1%Identity 85.4%

    Best alignment

    Query 197 to 333, hit 2414 to 2550. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCC 256
           |||||||||| || ||||| || |||||   ||| ||| ||||||| ||||||| | |||
Hit   2414 TGGAGCTGGGTGGAGGCCCGGGGGCAGGTGACCTTCAGACCTTGGCACTGGAGGTGGCCC 2473

Query  257 TGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGG 316
            ||||||||| ||||| ||||| || ||||| |||||||||||||| |||||||| ||||
Hit   2474 GGCAGAAGCGCGGCATCGTGGATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGG 2533

Query  317 AGAACTACTGCAACTAG 333
           |||||||||||||||||
Hit   2534 AGAACTACTGCAACTAG 2550

    117 of 137 identical, no gaps.

  21. JP 2004505619-A2004-02-26

    Vascular endothelial growth factor2

    HUMAN GENOME SCIENCES INC

    Query Match 26.1%Identity 85.4%

    Best alignment

    Query 197 to 333, hit 2414 to 2550. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCC 256
           |||||||||| || ||||| || |||||   ||| ||| ||||||| ||||||| | |||
Hit   2414 TGGAGCTGGGTGGAGGCCCGGGGGCAGGTGACCTTCAGACCTTGGCACTGGAGGTGGCCC 2473

Query  257 TGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGG 316
            ||||||||| ||||| ||||| || ||||| |||||||||||||| |||||||| ||||
Hit   2474 GGCAGAAGCGCGGCATCGTGGATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGG 2533

Query  317 AGAACTACTGCAACTAG 333
           |||||||||||||||||
Hit   2534 AGAACTACTGCAACTAG 2550

    117 of 137 identical, no gaps.

  22. EP 2804621-A12014-11-26

    GLUTAMIC ACID-STABILIZED INSULIN ANALOGUES

    UNIV CASE WESTERN RESERVE

    Query Match 25.5%Identity 97.8%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||  ||||||||||||||||||
Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACC 90

    88 of 90 identical, no gaps.

  23. JP 2015507916-A2015-03-16

    GLUTAMIC ACID-STABILIZED INSULIN ANALOGUES

    Case Western Reserve University

    Query Match 25.5%Identity 97.8%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
          ||||||||||  ||||||||||||||||||
Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACC 90

    88 of 90 identical, no gaps.

  24. EP 2061896-A12009-05-27

    Process for producing exogenous protein in the milk of transgenic mammals

    STERRENBELD BIOTECHNOLOGIE NOR

    Query Match 25.2%Identity 100.0%

    Best alignment

    Query 1 to 159, hit 11 to 169. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
          |||||||||||||  ||||| | |||||||||||| |||||||| ||||||   ||   |
Hit    11 ATGGCCCTGTGGACACGCCTGCGGCCCCTGCTGGCCCTGCTGGCGCTCTGGCCCCCCCCC 70

Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
          || |||   ||||| || ||||| || ||||| ||||| ||||||||||| || || |||
Hit    71 CCGGCCCGCGCCTTCGTCAACCAGCATCTGTGTGGCTCCCACCTGGTGGAGGCGCTGTAC 130

Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAG 159
          || |||||||| || || |||||||||||||| ||||||
Hit   131 CTGGTGTGCGGAGAGCGCGGCTTCTTCTACACGCCCAAG 169

    129 of 159 identical, no gaps.

  25. JP 2010528677-A2010-08-26

    Transgenic Mammals that Produce Exogenous Proteins in Milk

    Sterrenbeld Biotechnologie North America Inc

    Query Match 25.2%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 159, hit 11 to 169. Positions start at 1 and include both ends.

    Query   1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
          |||||||||||||  ||||| | |||||||||||| |||||||| ||||||   ||   |
Hit    11 ATGGCCCTGTGGACACGCCTGCGGCCCCTGCTGGCCCTGCTGGCGCTCTGGCCCCCCCCC 70

Query  61 CCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTAC 120
          || |||   ||||| || ||||| || ||||| ||||| ||||||||||| || || |||
Hit    71 CCGGCCCGCGCCTTCGTCAACCAGCATCTGTGTGGCTCCCACCTGGTGGAGGCGCTGTAC 130

Query 121 CTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAG 159
          || |||||||| || || |||||||||||||| ||||||
Hit   131 CTGGTGTGCGGAGAGCGCGGCTTCTTCTACACGCCCAAG 169

    129 of 159 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 60/929095.

  26. KR 1020030046425-A2003-07-09

    A PROTEIN FOR PREVENTING AND TREATING GALECTIN-3-ASSOCIATEDDISEASES AND USES THEREOF

    Query Match 25.1%Identity 79.5%

    Best alignment

    Query 11 to 181, hit 2802 to 2972. Positions start at 1 and include both ends.

    Query   11 GGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAG 70
           |||| ||| |||||||||||||||| |||||   ||||||||  ||   ||| |||   |
Hit   2802 GGATCCGCTTCCTGCCCCTGCTGGCCCTGCTCATCCTCTGGGAGCCCCGCCCTGCCCAGG 2861

Query   71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130
           | ||||| || || ||||| || || || ||| ||||||||||||||||||| ||||| |
Hit   2862 CTTTTGTCAAACAGCACCTTTGTGGTTCTCACTTGGTGGAAGCTCTCTACCTGGTGTGTG 2921

Query  131 GGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACC 181
           |||| || || |||||||||||||||| | ||||||| || |  |||||||
Hit   2922 GGGAGCGTGGATTCTTCTACACACCCATGTCCCGCCGCGAAGTGGAGGACC 2972

    136 of 171 identical, no gaps.

  27. WO 2015118353-A12015-08-13

    MOLECULAR DIAGNOSTIC TEST FOR PREDICTING RESPONSE TO ANTI-ANGIOGENIC DRUGS AND PROGNOSIS OF CANCER

    ALMAC DIAGNOSTICS LTD

    Query Match 24.9%Identity 100.0%Family of 4

    Best alignment and family

    Query 251 to 333, hit 1 to 83. Positions start at 1 and include both ends.

    Query 251 GGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACC 310
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 GGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACC 60

Query 311 AGCTGGAGAACTACTGCAACTAG 333
          |||||||||||||||||||||||
Hit    61 AGCTGGAGAACTACTGCAACTAG 83

    83 of 83 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  28. JP 2017518049-A2017-07-06

    METHODS OF CONSTRUCTING AMINO TERMINAL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

    THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH

    Query Match 23.6%Identity 98.8%

    Best alignment

    Query 73 to 153, hit 1 to 81. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
          ||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||
Hit     1 TTTGTGAACCAACACCTGTGCGGCTCAGACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60

Query 133 GAACGAGGCTTCTTCTACACA 153
          |||||||||||||||||||||
Hit    61 GAACGAGGCTTCTTCTACACA 81

    80 of 81 identical, no gaps.

  29. WO 2019243461-A12019-12-26

    PRODUCTION OF ENGINEERED DENDRITIC CELLS AND USES THEREOF

    FOND TELETHON

    Query Match 23.4%Identity 100.0%

    Best alignment

    Query 211 to 288, hit 1 to 78. Positions start at 1 and include both ends.

    Query 211 GGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGC 270
          ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit     1 GGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGC 60

Query 271 ATTGTGGAACAATGCTGT 288
          ||||||||||||||||||
Hit    61 ATTGTGGAACAATGCTGT 78

    78 of 78 identical, no gaps.

  30. US 11072792-B22021-07-27

    Materials and methods for treatment of usher syndrome type 2A

    BAYER HEALTHCARE LLC and CRISPR THERAPEUTICS AG

    Query Match 22.8%Identity 82.5%

    Best alignment

    Query 197 to 333, hit 4408 to 4536. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCC 256
           |||||||||| || |||||  |||       ||| ||| ||||||| ||||||| | |||
Hit   4408 TGGAGCTGGGTGGAGGCCC--GTGA------CCTTCAGACCTTGGCACTGGAGGTGGCCC 4459

Query  257 TGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGG 316
            ||||||||| ||||| ||||| || ||||| |||||||||||||| |||||||| ||||
Hit   4460 GGCAGAAGCGCGGCATCGTGGATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGG 4519

Query  317 AGAACTACTGCAACTAG 333
           |||||||||||||||||
Hit   4520 AGAACTACTGCAACTAG 4536

    113 of 137 identical, 8 gaps.

  31. US 12215316-B22025-02-04

    Materials and methods for treatment of usher syndrome type 2A

    CRISPR THERAPEUTICS AG and BAYER HEALTHCARE LLC

    Query Match 22.8%Identity 82.5%

    Best alignment

    Query 197 to 333, hit 4408 to 4536. Positions start at 1 and include both ends.

    Query  197 TGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCC 256
           |||||||||| || |||||  |||       ||| ||| ||||||| ||||||| | |||
Hit   4408 TGGAGCTGGGTGGAGGCCC--GTGA------CCTTCAGACCTTGGCACTGGAGGTGGCCC 4459

Query  257 TGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGG 316
            ||||||||| ||||| ||||| || ||||| |||||||||||||| |||||||| ||||
Hit   4460 GGCAGAAGCGCGGCATCGTGGATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGG 4519

Query  317 AGAACTACTGCAACTAG 333
           |||||||||||||||||
Hit   4520 AGAACTACTGCAACTAG 4536

    113 of 137 identical, 8 gaps.

  32. WO 2020206036-A12020-10-08

    NOVEL NUCLEIC ACID MODIFIER

    BROAD INST INC

    Query Match 22.7%Identity 92.8%

    Best alignment

    Query 229 to 331, hit 652 to 754. Positions start at 1 and include both ends.

    Query 229 CTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGT 288
          || ||| ||||||| |||||||   ||| ||||||||||||||||||||| || |||||
Hit   652 CTTCAGACCTTGGCACTGGAGGTTGCCCGGCAGAAGCGTGGCATTGTGGATCAGTGCTGC 711

Query 289 ACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACT 331
          ||||||||||||||||||||||| |||||||||||||||||||
Hit   712 ACCAGCATCTGCTCCCTCTACCAACTGGAGAACTACTGCAACT 754

    92 of 103 identical, no gaps.

  33. WO 2020206046-A12020-10-08

    METHODS AND COMPOSITIONS FOR CELL THERAPY

    BROAD INST INC

    Query Match 22.7%Identity 92.8%

    Best alignment

    Query 229 to 331, hit 652 to 754. Positions start at 1 and include both ends.

    Query 229 CTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGT 288
          || ||| ||||||| |||||||   ||| ||||||||||||||||||||| || |||||
Hit   652 CTTCAGACCTTGGCACTGGAGGTTGCCCGGCAGAAGCGTGGCATTGTGGATCAGTGCTGC 711

Query 289 ACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACT 331
          ||||||||||||||||||||||| |||||||||||||||||||
Hit   712 ACCAGCATCTGCTCCCTCTACCAACTGGAGAACTACTGCAACT 754

    92 of 103 identical, no gaps.

  34. US 10336817-B22019-07-02

    Therapeutic composition of camel milk

    Sultan Qaboos University

    Query Match 22.4%Identity 85.5%

    Best alignment

    Query 217 to 333, hit 9445 to 9561. Positions start at 1 and include both ends.

    Query  217 GGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTG 276
           || |||||   ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| |||
Hit   9445 GGGGCAGGTGACCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTG 9504

Query  277 GAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
           || || ||||| |||||||||||||| |||||||| |||||||||||||||||||||
Hit   9505 GATCAGTGCTGCACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 9561

    100 of 117 identical, no gaps.

  35. WO 2008150821-A12008-12-11

    Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1)

    Boehringer Ingelheim Pharma GmbH & Co. KG (DE)

    Query Match 22.2%Identity 100.0%

    Best alignment

    Query 1 to 74, hit 1 to 74. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60

Query 61 CCAGCCGCAGCCTT 74
         ||||||||||||||
Hit   61 CCAGCCGCAGCCTT 74

    74 of 74 identical, no gaps.

  36. JP 2010528614-A2010-08-26

    MODIFIED NUCLEOTIDE SEQUENCE ENCODING GLUCAGON-LIKE PEPTIDE-1 (GLP-1), NUCLEIC ACID CONSTRUCT COMPRISING SAME FOR PRODUCTION OF GLUCAGON-LIKE PEPTIDE (GLP-1), HUMAN CELLS COMPRISING SAID CONSTRUCT AND INSULIN-PRODUCING CONSTRUCTS AND METHODS OF USE THEREO

    REVATI J TATAKE,KELLI-ANN MONACO,MARGARET O'NEILL

    Query Match 22.2%Identity 100.0%

    Best alignment

    Query 1 to 74, hit 1 to 74. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60

Query 61 CCAGCCGCAGCCTT 74
         ||||||||||||||
Hit   61 CCAGCCGCAGCCTT 74

    74 of 74 identical, no gaps.

  37. US 7829664-B22010-11-09

    Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof

    Boehringer Ingelheim International GmbH

    Query Match 22.2%Identity 100.0%

    Best alignment

    Query 1 to 74, hit 13 to 86. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
         ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hit   13 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 72

Query 61 CCAGCCGCAGCCTT 74
         ||||||||||||||
Hit   73 CCAGCCGCAGCCTT 86

    74 of 74 identical, no gaps.

  38. EP 2425001-A22012-03-07

    COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

    UNIV CALIFORNIA

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6800 to 6905. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6800 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6859

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6860 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6905

    93 of 106 identical, no gaps.

  39. EP 2586867-A12013-05-01

    Transient expression lentiviral vectors, preparation and uses thereof

    NEWVECTYS

    Query Match 22.1%Identity 87.7%Family of 2

    Best alignment and family

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. WO 2013060819-A22013-05-02

    TRANSIENT EXPRESSION VECTORS, PREPARATION AND USES THEREOF

    NEWVECTYS

    Query Match 22.1%Identity 87.7%Family of 2

    Best alignment and family

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  41. EP 2728005-A12014-05-07

    LRP1 AS KEY RECEPTOR FOR THE TRANSFER OF STERIFIED CHOLESTEROL FROM VERY-LOW-DENSITY LIPOPROTEINS (VLDL) TO ISCHAEMIC CARDIAC MUSCLE

    CONSEJO SUPERIOR INVESTIGACION

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 8228 to 8333. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   8228 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 8287

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   8288 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 8333

    93 of 106 identical, no gaps.

  42. US 8728458-B22014-05-20

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6800 to 6905. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6800 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6859

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6860 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6905

    93 of 106 identical, no gaps.

  43. US 9096671-B22015-08-04

    LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle

    CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) and INSTITUTO CATALAN DE CIENCIAS CARDIOVASCULARES (ICCC)

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 8228 to 8333. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   8228 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 8287

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   8288 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 8333

    93 of 106 identical, no gaps.

  44. WO 2017068077-A12017-04-27

    METHODS AND PRODUCTS FOR GENETIC ENGINEERING

    INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.

  45. JP 2018531023-A2018-10-25

    METHODS AND PRODUCTS FOR GENETIC ENGINEERING

    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.

  46. KR 1020190110133-A2019-09-27

    MULTIPLE MALARIA PRE-ERYTHROCYTIC ANTIGENS AND THEIR USE IN THE ELICITATION OF A PROTECTIVE IMMUNE RESPONSE IN A HOST

    INSTITUT PASTEUR

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6668 to 6773. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6668 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6727

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6728 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6773

    93 of 106 identical, no gaps.

  47. WO 2019224606-A12019-11-28

    MALARIA PRE-ERYTHROCYTIC ANTIGENS AS A FUSION POLYPEPTIDE AND THEIR USE IN THE ELICITATION OF A PROTECTIVE IMMUNE RESPONSE IN A HOST

    PASTEUR INSTITUT

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6668 to 6773. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6668 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6727

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6728 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6773

    93 of 106 identical, no gaps.

  48. WO 2020035779-A12020-02-20

    UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS

    NOVARTIS AG

    Query Match 22.1%Identity 87.7%Family of 4

    Best alignment and family

    Query 228 to 333, hit 6662 to 6767. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6662 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6721

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6722 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6767

    93 of 106 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  49. US 10968253-B22021-04-06

    Methods and products for genetic engineering

    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), ECOLE NORMALE SUPERIEURE DE LYON and UNIVERSITE CLAUDE BERNARD LYON 1

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.

  50. JP 2021534147-A2021-12-09

    UREA COMPOUNDS AND USES THEREOF

    NOVARTIS AG

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
           ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841

Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
            |||||||||||||| |||||||| |||||||||||||||||||||
Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887

    93 of 106 identical, no gaps.